enGene Therapeutics

ENGN

Börsenwert 112 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
51	51 Point72 Asset Management Stamford, Connecticut	24.206 $	-649.981 $	-159.399	-92 %
52	52 Virtu Financial New York	24.000 $	+57.031 $	+13.986	Neu
53	53 Royal Bank of Canada Toronto, Ontario, Canada	20.000 $	+3.181 $	+780	+7 %
54	54 PFS Partners Mine Hill, New Jersey	19.030 $	–	–	–
55	55 Wells Fargo San Francisco, California	11.833 $	-22.945 $	-5.627	-45 %
56	56 Wolverine Asset Management Chicago, Illinois	5.128 $	+12.086 $	+2.964	Neu
57	57 Simplex Trading Chicago, Illinois	690 $	+1.627 $	+399	Neu
58	58 Farther Finance Advisors San Francisco, California	173 $	+408 $	+100	Neu
59	59 Aquatic Capital Management Chicago, Illinois	50 $	-5.505 $	-1.350	-98 %
60	60 SBI Securities Tokyo, Japan	48 $	–	–	–
61	61 VR Adviser New York	–	-32,5 Mio. $	-4.771.414	Geschlossen
62	62 Blue Owl Capital Holdings New York	–	-30,1 Mio. $	-4.416.353	Geschlossen
63	63 Deep Track Capital Greenwich, Connecticut	–	-29,8 Mio. $	-4.377.572	Geschlossen
64	64 Braidwell Stamford, Connecticut	–	-16,7 Mio. $	-2.456.870	Geschlossen
65	65 MPM BioImpact Boston, Massachusetts	–	-12,6 Mio. $	-1.845.373	Geschlossen
66	66 Franklin Resources San Mateo, California	–	-8,96 Mio. $	-1.314.993	Geschlossen
67	67 Polar Capital Holdings London, United Kingdom	–	-8,34 Mio. $	-1.224.071	Geschlossen
68	68 Marshall Wace London, United Kingdom	–	-2,34 Mio. $	-343.928	Geschlossen
69	69 Monashee Investment Management Boston, Massachusetts	–	-2,18 Mio. $	-320.000	Geschlossen
70	70 Birchview Capital Burlington, Vermont	–	-1,7 Mio. $	-250.000	Geschlossen
71	71 Fidelity Investments Boston, Massachusetts	–	-1,58 Mio. $	-232.200	Geschlossen
72	72 Trexquant Investment Stamford, Connecticut	–	-712.987 $	-104.697	Geschlossen
73	73 Deeter Investments Austin, Texas	–	-612.900 $	-90.000	Geschlossen
74	74 Geode Capital Management Boston, Massachusetts	–	-264.242 $	-38.802	Geschlossen
75	75 American Century Companies Kansas City, Missouri	–	-223.783 $	-32.861	Geschlossen

enGene Therapeutics ENGN Börsenwert 112 Mio. $

enGene Therapeutics

ENGN

Börsenwert 112 Mio. $